Biomerica Inc.
Maker of diagnostic test kits that analyze blood, urine, nasal or fecal samples to detect diseases, food intolerances and other medical conditions, sold to clinical labs and point-of-care settings worldwide.
From the annual report
THE COMPANY We are a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Our diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients to aid in the diagnosis of diseases, food intolerances, and other medical conditions. These tests detect and measure the presence and levels of specific bacteria, hormones, antibodies, antigens and other substances that may exist in the human body at extremely low concentrations. Our products are designed to enhance patient outcomes and well-being while reducing total healthcare costs. We sell our portfolio of diagnostic products worldwide, primarily to clinical laboratories and in point-of-care settings, including physicians’ offices and over-the-counter channels. We also provide contract development and manufacturing services to third parties that utilize the technology underlying our products. In addition, we are commercializing our inFoods IBS product through physician-directed and laboratory-based channels, including third-party reimbursement pathways. Most of our products carry Conformit Europ enne ( CE ) marking and/or are registered with regulatory agencies in various countries for diagnostic use, with several also cleared by the United States Food and Drug Administration ( FDA ) for sale in the United States.
Run a full DCF model with Monte Carlo simulation.